Delhi AIIMS chief Dr. Randeep Guleria said that Covaxin's data for children after completion of the Phase 2/3 trials will be available by September and the approval is expected the same month.
https://ift.tt/eA8V8J Delhi AIIMS chief Dr. Randeep Guleria said that Covaxin's data for children after completion of the Phase 2/3 trials will be available by September and the approval is expected the same month. from Zee News :India National https://ift.tt/3xFV2wH
No comments:
Post a Comment